• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗对非小细胞肺癌整体基因表达的影响。

Effects of chemotherapy on global gene expression in non-small cell lung cancer.

作者信息

Li J, Shi R, Yu P

机构信息

Department of Lung Tumor, Sichuan Cancer Hospital, Chengdu, Sichuan Province, China.

出版信息

Eur Rev Med Pharmacol Sci. 2014;18(1):126-31.

PMID:24452953
Abstract

INTRODUCTION

Gene expression profiles of peripheral blood monocytes from patients with non-small cell lung cancer (NSCLC) before and after chemotherapy were used to investigate the effect of chemotherapy on gene expression.

MATERIALS AND METHODS

Microarray dataset GSE39345 was downloaded from Gene Expression Omnibus, including 32 NSCLC samples before chemotherapy, 17 NSCLC samples after chemotherapy and 20 healthy samples. Raw data pretreatment and differentially expressed genes (DEGs) analysis between health and NSCLC samples before chemotherapy, health and NSCLC samples after chemotherapy were performed with packages of R. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was done for the common DEGs with WebGestalt to investigate their underlying function.

RESULTS

A total of 904 DEGs were identified in health vs. NSCLC samples before chemotherapy and 2148 in health vs. NSCLC samples after chemotherapy. Further, they were divided into three sets: 584 common DEGs, 320 unique DEGs (health vs NSCLC samples before chemotherapy), and 1564 unique DEGs (health vs NSCLC samples after chemotherapy). Function enrichment analysis showed that these common DEGs were associated with cell cycle and cell differentiation.

CONCLUSIONS

Chemotherapy could not completely reverse the lung cancer development because several cell growth-related genes are still present even after chemotherapy.

摘要

引言

利用非小细胞肺癌(NSCLC)患者化疗前后外周血单核细胞的基因表达谱来研究化疗对基因表达的影响。

材料与方法

从基因表达综合数据库下载微阵列数据集GSE39345,包括32例化疗前的NSCLC样本、17例化疗后的NSCLC样本和20例健康样本。使用R软件包对原始数据进行预处理,并分析化疗前健康样本与NSCLC样本、化疗后健康样本与NSCLC样本之间的差异表达基因(DEG)。利用WebGestalt对共同的DEG进行京都基因与基因组百科全书(KEGG)通路富集分析,以研究其潜在功能。

结果

化疗前健康样本与NSCLC样本之间共鉴定出904个DEG,化疗后健康样本与NSCLC样本之间共鉴定出2148个DEG。进一步将它们分为三组:584个共同的DEG、320个独特的DEG(化疗前健康样本与NSCLC样本)和1564个独特的DEG(化疗后健康样本与NSCLC样本)。功能富集分析表明,这些共同的DEG与细胞周期和细胞分化相关。

结论

化疗不能完全逆转肺癌的发展,因为即使在化疗后仍存在一些与细胞生长相关的基因。

相似文献

1
Effects of chemotherapy on global gene expression in non-small cell lung cancer.化疗对非小细胞肺癌整体基因表达的影响。
Eur Rev Med Pharmacol Sci. 2014;18(1):126-31.
2
Effect evaluation of cisplatin-gemcitabine combination chemotherapy for advanced non-small cell lung cancer patients using microarray data.利用微阵列数据评估顺铂-吉西他滨联合化疗对晚期非小细胞肺癌患者的疗效
Eur Rev Med Pharmacol Sci. 2015 Feb;19(4):578-85.
3
Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.TTK 作为非小细胞肺癌预后生物标志物的生物信息学分析和实验验证。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20202711.
4
Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells.硼替佐米诱导非小细胞肺癌和血液单核细胞中吉西他滨药代动力学和药效学的时变调节。
Mol Cancer Ther. 2009 May;8(5):1026-36. doi: 10.1158/1535-7163.MCT-08-0700. Epub 2009 Apr 21.
5
Clinical significance of circPVT1 in patients with non-small cell lung cancer who received cisplatin combined with gemcitabine chemotherapy.circPVT1 在接受顺铂联合吉西他滨化疗的非小细胞肺癌患者中的临床意义。
Tumori. 2021 Jun;107(3):204-208. doi: 10.1177/0300891620941940. Epub 2020 Jul 31.
6
GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation.GOLM1 预测 NSCLC 患者的预后不良,并与 NSCLC 细胞中顺铂的增殖和化疗敏感性相关:生物信息学分析和实验室验证。
J Bioenerg Biomembr. 2021 Apr;53(2):177-189. doi: 10.1007/s10863-021-09875-7. Epub 2021 Feb 4.
7
Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer.早期非小细胞肺癌中微小RNA和差异表达基因的鉴定
Oncol Rep. 2016 Apr;35(4):2171-6. doi: 10.3892/or.2016.4561. Epub 2016 Jan 14.
8
[Advances of drug resistance marker of gemcitabine for non-small cell lung cancer].[吉西他滨用于非小细胞肺癌的耐药标志物研究进展]
Zhongguo Fei Ai Za Zhi. 2011 May;14(5):421-8. doi: 10.3779/j.issn.1009-3419.2011.05.08.
9
Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy.一线联合化疗治疗晚期非小细胞肺癌患者外周免疫细胞基因表达变化。
PLoS One. 2013;8(2):e57053. doi: 10.1371/journal.pone.0057053. Epub 2013 Feb 25.
10
Mechanism underlying the effect of Liujunzi decoction on advanced-stage non-small cell lung cancer in patients after first-line chemotherapy.六君子汤对一线化疗后晚期非小细胞肺癌患者的作用机制。
J Tradit Chin Med. 2022 Feb;42(1):108-115. doi: 10.19852/j.cnki.jtcm.2022.01.007.